Futura Medical Share Discussion Threads

[lbo] 05/9/2022 12:14

So up to 72% of men under 40 who self treat with an OTC Med3000 medical device gel. Could be inappropriately and delaying treating the real underlying cause of their ED? Thats a serious risk from an OTC product like Med3000 that could lead to a dangerous reversal in the ' higher rate of prescribing' that was seen with the the Pharmacists assessment with Sildenafil becoming a Pharmacy medicine and missing an ‘opportunity for monitoring of linked risk factors, such as diabetes mellitus, dyslipidaemia, and vascular disorders’.https://www.karger.com/Article/Fulltext/354931There are a significant number of men under 40 who experience erectile dysfunction (ED). In the past, the vast majority of cases were thought to be psychogenic in nature. Studies have identified organic etiologies in 15-72% of men with ED under 40. Organic etiologies include vascular, neurogenic, Peyronie's disease (PD), medication side effects and endocrinologic sources. Vascular causes are commonly due to focal arterial occlusive disease. Young men with multiple sclerosis, epilepsy and trauma in close proximity to the spinal cord are at increased risk of ED. It is estimated that 8% of men with PD are under 40, with 21% of these individuals experiencing EDhttps://bjgpopen.org/content/5/2/bjgpopen20X101145Sildenafil and tadalafil are recommended firstline treatments for erectile dysfunction (ED). Sildenafil was legally reclassified to a pharmacy medicine in the UK in 2018.The two-fold increase in the rate of primary care prescriptions in the past 10 years suggests that more men are being screened for, or seeking help for, ED. The higher rate of prescribing offers opportunity for monitoring of linked risk factors, such as diabetes mellitus, dyslipidaemia, and vascular disorders

[lbo] 05/9/2022 12:09

Viagra studies have showed men taking it live longer. No studies have showed that men taking MED3000 live longer. And if men incorrectly diagnose and self treat with MED3000. It could mean the real serious cause of the ED is delayed in being diagnosed and could lead to death.





Figures released by the British Association of Urological Surgeons show that 90 per cent of men with impotence have at least one underlying physical cause for their problem, with 40 per cent living with cardiovascular disease and 33 per cent with diabetes.

Cardiovascular disease is the leading cause of death globally, claiming an estimated 17.9 million lives each year according to the World Health Organisation.

[lbo] 05/9/2022 12:01

Yet in FM71 only headaches and non cardiac chest pain were reported with Tadalafil. But with MED3000 headaches, nauses and penile pain were reported. And all the while Tadalafil was still more effective.




De Novo-winning devices often lack effectiveness data, analysis shows

[lbo] 05/9/2022 11:11

Med3000 is just a class 2 medical device. Similar to lubricants and arousal gels already on the market.



Devices are subject to weaker standards than drugs because they’re re regulated under a different law. The Medical Device Amendments of 1976 was intended to encourage innovation while allowing for a range of review standards based on risk, according to legal expert Richard A. Merrill. An array of corporate lobbying has since prompted Congress to ease regulations and make it easier for devices to get the FDA OK (here’s s one 2015 example).

Journalists need to scrutinize the claims
Journalists have a responsibility to report this lack of evidence, but they often don’t. Investigative journalist Jeanne Lenzer, who wrote a book about the under-regulated medical device industry, says more dogged reporting is needed: We really don’t know what we’re getting with many of these devices

Ninety-nine percent of devices never have to provide clinical data, thanks in part to the 2002 Medical Devices User Fee Act, which requires the FDA to use the least burdensome route

For the few devices subject to a scientific review, the quality standards are flimsy. Randomized controlled trials, the gold standard, are infrequent. Most studies are unblinded, and thus prone to bias. The FDA settles for loosely defined ‘reasonable assurance’ that a device is safe and effective, versus its higher standard of substantial evidence for drugs, which require studies with comparison groups that didn’t receive the same treatment. Thus, data that would never be sufficient to support the approval of a drug can result in the approval of a device used to treat the same condition, potentially diverting patients from effective drugs to less-effective devices.

[broomrigg] 05/9/2022 10:54

No doubt Eroxon will fly off the shelves.....the shares will fly too. It takes only 10 mins to kick-in; a great selling point as is the almost zero side-effects. This product is a dead cert.

Ever tried the pills? Of course you have and they give you a right rotten stuffy headache that hardly helps, don't they. They are dangerous to many of the men in the age group they are aimed at and most useful too.

[lbo] 05/9/2022 09:47

I see that website has a clear link to its terms of use disclaimers:

‘Reliance on information posted and disclaimer

The materials contained on this website are of a general, informative nature. Futura has used reasonable endeavours to ensure the quality, accuracy and completeness of the contents of the pages on this website; however, no information contained on this website shall constitute an invitation to invest or otherwise deal in the shares of Futura. Any investment decision is made of your own volition and no communication by Futura should be treated as an invitation or inducement to engage in investment activity.
Some material provided on this website may relate to medical, health or fitness conditions, their prevention and treatment. Such material is provided for information purposes only. It is not, and is not meant to be, a substitute for advice that should be provided by a physician or medical professional. You should not use the information on this website for diagnosing a health or fitness problem or disease, but should always take advice from your own physician or medical adviser.




‘Clinically proven? Says who?

When they say “clinically proven,” your first question should be, “oh yeah, says who?”

It is possible the company selling the supplement, infomercial ab gadget, or balance device did a poorly controlled “study” where they had people try the product and then tell the company about their results.

While this seems logical enough, it does not constitute legitimate research’

[broomrigg] 05/9/2022 09:08

Looking good here.

Website if you haven't already seen it....



:-)

[petroc] 03/9/2022 19:00

Serious question, lbo. This is a pretty binary situation, MED3000 will either sell or it won't. In either case, your work will have been done, all 5 years of it. What will you do then? Will you continue to bash FUM for any other products they might bring out? Or just retire from bashing?

[lbo] 03/9/2022 12:59

There is also a lot of other reported benefits from taking Oral PDE5 drugs.




Patients taking the male impotence drug were found to have a lower risk of having a heart attack or dying from heart failure than those not on the medication.



Viagra could help men to live LONGER: Blue pill prolongs life and prevents heart attacks in males with coronary artery disease, study finds



Taking Viagra halves the risk of men who suffer from type 2 diabetes dying from heart problems



Taking Viagra could cut your risk of developing Alzheimer's by up to 69%



Viagra and other erectile dysfunction drugs may reduce risk of death from colon cancer by 20%

[lbo] 03/9/2022 12:35

ED is primarily a self-assessed condition.

Clinical assessment of the therapeutic intervention is not done with a measurable laboratory value or physical finding but is derived from patient reporting and indirectly from partner perception.

In the course of ED evaluation, therapy selection, and outcome assessment, the patient and physician enter into an intimate communicative relationship in which there is some element of bias. Physician bias arises from the desire to achieve an excellent response without side effects, and patient bias may occur in the additive unconscious need to please the physician. This may lead to treatment outcome inaccuracies, with an over-reporting of efficacy and an under-reporting of treatment side effects.




The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient

Percentage change from baseline has the lowest statistical power and was highly sensitive to changes in variance.

[lbo] 03/9/2022 09:57

Unfair commercial practices

When you buy goods and services anywhere in the EU from a website, a local shop or a seller outside your home country’s EU law protects you against unfair commercial practices. When promoting, selling or supplying products, companies must give you enough accurate information to enable you to make an informed buying decision. Find out more about contract information. If they fail to provide this information, their actions may be considered unfair. You have the right to seek redress if you are treated unfairly.

Misleading and aggressive practices

You are protected against 2 main categories of unfair commercial practices: misleading practices, either through action (giving false information) or omission (leaving out important information) aggressive practices that aim to bully you into buying Certain commercial practices are prohibited in all circumstances. Some of the most common are listed below:

Whenever a product is advertised as therapeutic, curing allergies, reversing hair loss, helping you lose weight, etc. you have the right to know if such claims have been scientifically confirmed. In many cases, claims like these are not medically backed up and are simply too good to be true

[petroc] 02/9/2022 23:21

That's the best you've got, LiarBO? Bwahahahahahaha! You absolute cretin!

[lbo] 02/9/2022 22:34

Yet Flexiseq also tried to make similar unsubstantiated claims about its gel and it is also just a class 2b medical device same as MED3000 and went through the same CE Mark medical device process.





One specialist commentator felt that the clinical effectiveness has not been demonstrated. The absence of an adequate placebo (an inactive topical gel) for highlighted as a limitation by 3 commentators. One commentator said that without it, the clinical effectiveness could be attributed to the placebo effect of rubbing a gel


That's the danger in measuring a subjective outcome of just an individuals perception or as Futura said ‘ where patients noticed’ LOL Unfortunately, subjective outcomes can't be avoided for many indications, such as libido or pain management which is why studies need to blinded and adequately controlled to substantiate any claims. FM71 had so many uncontrolled variables and was weighted towards just subjective less scientific measurements. The only thing that can really be claimed and substantiated from FM57 and FM71 is that any medical device gel that is rubbed can have placebo effects in pain and ED.



Comparisons against baseline within randomised groups are often used and can be highly misleading

[petroc] 02/9/2022 20:48

LiarBO always brings up Flexiseq when he's rattled. He fails to mention that Flexiseq was a Russian backed treatment, and the brother of the oligarch who bought the rights for it was a known gangster who was going to distribute it. Shame on you, LiarBO.